US Patent

US10842770 — Non-aqueous taxane pro-emulsion formulations and methods of making and using the same

Method of Use · Assigned to Teikoku Pharma USA Inc · Expires 2031-08-07 · 5y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects non-aqueous taxane pro-emulsion formulations and methods of making and using them, including kits that include these formulations.

USPTO Abstract

Non-aqueous taxane pro-emulsion formulations are provided. Pro-emulsion formulations of embodiments of the invention include a taxane, an oil component, a surfactant component and, optionally, a non-aqueous solvent component. Also provided are methods of making and using the pro-emulsion formulations, as well as kits that include the pro-emulsion formulations.

Drugs covered by this patent

Taxotere (Docetaxel) · Sanofi

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2998`	—	Taxotere
`U-2998`	—	Taxotere
`U-2998`	—	Taxotere

Patent Metadata

Patent number: US10842770
Jurisdiction: US
Classification: Method of Use
Expires: 2031-08-07
Drug substance claim: No
Drug product claim: Yes
Assignee: Teikoku Pharma USA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.